awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52633900-94BE8186-D34F-495B-A0F9-769E65E2F5A5
Q52633900-94BE8186-D34F-495B-A0F9-769E65E2F5A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52633900-94BE8186-D34F-495B-A0F9-769E65E2F5A5
Transitioning patients with immune thrombocytopenia to second-line therapy: Challenges and best practices.
P2860
Q52633900-94BE8186-D34F-495B-A0F9-769E65E2F5A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52633900-94BE8186-D34F-495B-A0F9-769E65E2F5A5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
15df3a423191daf21744f2becfcc9da94a9fa4ea
P2860
A 2-Year, Longitudinal, Prospective Study of the Effects of Eltrombopag on Bone Marrow in Patients with Chronic Immune Thrombocytopenia.